Sadly this looks like it could take off again regardless of the record vaccinations that have occurred in the USA
The variant B1526 is rising in NYC. It now represents about 40% of all sequenced cases with S-gene dropout. The B1526 with E484K mutation is about half of these cases, at about 20%. NYC trends in cases, hospitalizations look concerning. A key question: how much is B1526 a factor?
Cell Therapy News/Articles, page-8509
-
- There are more pages in this discussion • 9,930 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |